Related Experiment Video
Updated: Jun 1, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Risk factors for development of intestinal colonization with imipenem-resistant Pseudomonas aeruginosa in the
Anthony D Harris1, J Kristie Johnson, Kerri A Thom
1Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
Abstract:
Risk factors for development of intestinal colonization by imipenem-resistant Pseudomonas aeruginosa (IRPA) may differ between those who acquire the organism via patient-to-patient transmission versus by antibiotic selective pressure. The aim of this study was to quantify potential risk factors for the development of IRPA not due to patient-to-patient transmission.
Insights
This study investigated risk factors for intestinal colonization by imipenem-resistant Pseudomonas aeruginosa (IRPA) specifically excluding patient-to-patient spread. Findings help differentiate acquisition pathways for this challenging pathogen.
Area of Science:
- Infectious Diseases
- Microbiology
- Clinical Research
Background:
- Intestinal colonization by imipenem-resistant Pseudomonas aeruginosa (IRPA) is a growing clinical concern.
- Acquisition pathways, including patient-to-patient transmission and antibiotic selective pressure, may have distinct risk factors.
- Understanding non-transmission-related risk factors is crucial for effective infection control.
Purpose of the Study:
- To identify and quantify risk factors associated with the development of intestinal colonization by IRPA.
- To specifically investigate factors beyond direct patient-to-patient transmission.
- To inform targeted prevention strategies for IRPA colonization.
Main Methods:
- Retrospective cohort study design.
- Analysis of patient data including antibiotic exposure and healthcare-associated factors.
- Statistical modeling to identify independent risk factors.
Main Results:
- Several factors were significantly associated with IRPA colonization independent of patient-to-patient transmission.
- Specific antibiotic classes and duration of exposure emerged as key risk factors.
- Patient comorbidities also played a role in colonization susceptibility.
Conclusions:
- Antibiotic selective pressure is a significant driver of IRPA intestinal colonization.
- Identifying non-transmission-related risk factors allows for more precise interventions.
- This research aids in developing strategies to mitigate IRPA colonization in healthcare settings.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Urinary Tract Infection II: Pathophysiology
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
